Agilent Technologies, Inc.

A Healthcare Diagnostics & Research

Agilent Technologies, Inc.’s revenue for fiscal 2025 (year ended October 2025) was $6.9 billion, up 6.73% from fiscal 2024. In the quarter to July 2026, revenue grew 8.06%, EPS grew 8.47%, free cash flow grew 69.5% and total debt rose 8.81%, each against the same quarter a year earlier. Member of the S&P 500; dividend growth for ten consecutive years.

172.97 2.58 −1.47%
Market cap
$49.5B
P/E
34.0×
Fwd P/E
26.3×
Dividend yield
0.59%
F-score
5/9
Altman Z
5.46
Beneish M
−2.46
Dividend safety
86/100

Agilent Technologies, Inc. (A) Free cash flow

Alert me on Free cash flow

Agilent Technologies, Inc.'s free cash flow for fiscal 2025 was $1.2B, down 16.1% from $1.4B in fiscal 2024. Over the twelve months to 31 July 2026 it was $1.3B. Over the past ten years it has ranged from $426.0M (fiscal 2015) to $1.5B (fiscal 2023); the current reading is higher than 73% of that period. Agilent Technologies, Inc. ranks 5th of 52 Diagnostics & Research companies by free cash flow.

Free cash flow, annual

Embed this chart

Annual newest first

Period Free cash flow Change
FY2025 $1.2B (16.10%)
FY2024 $1.4B (6.85%)
FY2023 $1.5B 44.37%
FY2022 $1.0B (21.28%)
FY2021 $1.3B 61.52%
FY2020 $803.0M (7.17%)
FY2019 $865.0M (5.05%)
FY2018 $911.0M 27.77%
FY2017 $713.0M 9.02%
FY2016 $654.0M 53.52%

Quarterly newest first

Period Free cash flow Change
Jul 2026 $439.0M 118.41%
Apr 2026 $201.0M 14.86%
Jan 2026 $175.0M (61.28%)
Oct 2025 $452.0M 74.52%
43 more quarters

Against its own ten years

Low $426.0M High $1.5B
Ten-year median $911.0M
Current reading's percentile 73

Free cash flow against peers

What Free cash flow is

Free Cash Flow tells an investor how much cash a company’s operations generate after paying for its investment in physical and intangible assets.

Operating Cash Flow + Property, Plant, Equipment Change (Net) + Intangible Assets Change (Net)

The full definition of Free cash flow →

More on A